440 likes | 727 Views
Introduction. We routinely prescribe teratogenic medications to women of childbearing age.Examples: statins, ace inhibitors, coumadin, tetracycline, doxycycline, streptomycin, phenytoin, valproic acid, carbamazepine, lithium. . Question . What are the advantages, disadvantages, side effects and contraindications of the following contraceptive methods? Barrier MethodsOral Contraceptive PillsInjectable ContraceptivesContraceptive PatchVaginal RingIntrauterine Devices.
E N D
1. Contraception Elizabeth Dehmer
Special Month Presentation
Aug. 20, 2008
2. Introduction We routinely prescribe teratogenic medications to women of childbearing age.
Examples: statins, ace inhibitors, coumadin, tetracycline, doxycycline, streptomycin, phenytoin, valproic acid, carbamazepine, lithium.
3. Question What are the advantages, disadvantages, side effects and contraindications of the following contraceptive methods?
Barrier Methods
Oral Contraceptive Pills
Injectable Contraceptives
Contraceptive Patch
Vaginal Ring
Intrauterine Devices
4. Barrier Methods Condoms
Female Condoms
Cervical Cap
Diaphragm
5. Condoms Acts as barrier against passage of semen into vagina
Good for individuals who have multiple partners, and individuals who do not want medical intervention for contraception.
6. Condoms Advantages:
Protects against STDs
Readily available
Inexpensive
Allows male partner to be involved in contraception Disadvantages
Failure rate: 2% for perfect use? 15% with typical use
Requires responsible attitude on the part of the male
May decrease enjoyment of sex
Lots of ways to have errors with condoms that can lead to failure: failure to use with every act of intercourse, improper lubricant use with latex condoms (oil-based lubricants), incorrect placement of condom, poor w/drawal technique (without securing condom), opening condom packet carelessly with fingernails, teeth, or sharp objects, not checking expiration date, unrolling condom before putting it on can increase chance of tearing, using wrong size of condom, using too little or too much lubricant. Lots of ways to have errors with condoms that can lead to failure: failure to use with every act of intercourse, improper lubricant use with latex condoms (oil-based lubricants), incorrect placement of condom, poor w/drawal technique (without securing condom), opening condom packet carelessly with fingernails, teeth, or sharp objects, not checking expiration date, unrolling condom before putting it on can increase chance of tearing, using wrong size of condom, using too little or too much lubricant.
7. Female Condoms Polyurethane sheath intended for one-time use with two flexible rings.
Acts as a barrier to passage of semen into vagina Ring at closed end of sheath serves as insertion mechanism and internal anchor placed inside the vagina. Second ring remains outside of the canal after insertion.Ring at closed end of sheath serves as insertion mechanism and internal anchor placed inside the vagina. Second ring remains outside of the canal after insertion.
8. Female Condoms Advantages
Protects against STDs
Can be inserted up to 8 hrs before intercourse
Sheath coated on inside with silicone based lubricant
Disadvantages
More expensive than condoms
Awkward, difficult to place
May cause UTI
Failure rate: 5% perfect use?21% typical use $2-2.50 compared to 25-50 cents for condoms
Can cause UTI if left in for a prolonged period$2-2.50 compared to 25-50 cents for condoms
Can cause UTI if left in for a prolonged period
9. Cervical Cap Cup-shaped latex device fits over the base of the cervix
Spermicide required
May be inserted up to 8 hrs prior to intercourse and left in place for 48 hrs. Spermicide to fill 1/3 of the way fullSpermicide to fill 1/3 of the way full
10. Cervical Cap Advantages
Provides continuous protection for duration of use regardless of number of intercourse acts, and does not require additional spermicide
Non-hormonal
Disadvantages
Requires professional fitting and training
Can lead to cervical erosions Obesity can make placement difficult
High failure rate (In nulliparous women 6% with perfect use, 16% with typical. In parous women, 26% with perfect use, 32% typical use)
Risk of toxic shock syndrome of left in place longer than prescribed period
Requires h/o normal pap smears
11. Diaphragms Shallow cap with spring mechanism in rim to hold in place in vagina
Spermicide required
Must be left in place 6hrs following intercourse
12. Diaphragms Advantages
Non-hormonal contraception controlled by woman
Disadvantages
High failure rate: perfect use 6%, typical use 16%
Prolonged use can increase risk of UTIs Requires professional fitting and training
Can develop odor if not properly cleaned
Can cause vaginal erosions
Requires additional spermicide for repeated use
13. Oral Contraceptive Pills Combined Oral Contraceptive Pills
Extended-cycle/continuous Oral Contraceptive Pills
Progestin-Only Contraceptive Pills
Emergency Contraception
14. Combined Oral Contraceptive Pills Contain estrogen and progestin
Monophasic
Multiphasic
Block ovulation, alter cervical mucus, stimulate atrophic change in endometrium
21 days of hormone followed by 7 days of placebo to allow withdrawal bleeding
Monophasic: equal quantity of hormone in each tablet
Multiphasic: contain varying amounts of estrogen and progestin in active pills in an attempt to mimic natural hormone fluctuations and provide lowest effective dose of hormone. Monophasic: equal quantity of hormone in each tablet
Multiphasic: contain varying amounts of estrogen and progestin in active pills in an attempt to mimic natural hormone fluctuations and provide lowest effective dose of hormone.
15. Combined Oral Contraceptive Pills Advantages:
Failure rate less than 0.3% with perfect use (8% typical use)
Fertility returns rapidly
Bleeding is decreased
Greater cycle predictability
Decreased risk of benign breast disease, PID, ovarian and endometrial cancers
Disadvantages:
Increased risk of stroke, acute MI, venous thromboembolic disease
Increased risk of hepatic adenoma, cervical cancer, breast cancer
Do not protect against STDs
When used with antibiotics or anticonvulsants, efficacy may be decreased
**Patients at higher risk of thromboembolism are sedentary, overweight, smokers, hypertensive, diabetic, hypercholesterolemic**Patients at higher risk of thromboembolism are sedentary, overweight, smokers, hypertensive, diabetic, hypercholesterolemic
16. Combined OCPs: Side effects Nausea
Headache
Weight gain
Vomiting
Dizziness
Mastalgia
Melasma
Hypertension Mood changes
Decreased libido
Increased triglycerides
Severe depression
Spotting, breakthrough bleeding Side effects usually subside within first few months of initiation
Melasma-skin condition: brown patches on the face Side effects usually subside within first few months of initiation
Melasma-skin condition: brown patches on the face
17. Combined OCPs: Contraindications Smoker of age > 35
Encourage smoking cessation in patients younger than 35
History of breast cancer
Abnormal vaginal bleeding of unknown etiology
Cerebrovascular disease
Congenital hyperlipidemia
Ischemic heart disease
Migraine
Active viral hepatitis
Diabetes >20 years OR with severe vascular disease, nephropathy, retinopathy, neuropathy
Major surgery with prolonged immobilization
Severe hypertension
Hepatic neoplasm
Impaired liver function
Thrombophlebitis, thromboembolic disease, known thrombogenic mutations
18. Combined OCPs: Examples Monophasic:
Ortho-cyclen
OrthoNovum
Lo/Ovral
Low-Ogestrel
Nordette
Loestrin 1.5/30 and 1/20
Alesse
Yasmin
Multiphasic:
Ortho Tri-Cyclen
Cyclessa
Ortho-Novum 777
TriNorinyl
Triphasil
Tri-Levlen
Trivora
Estrostep
Start date varies: on day 1 of menstruation, first Sunday after menstruation, day 5 of cycle
Yasmin: contains synthetic progestin chemically related to spironolactone (with anti-androgen and anti-mineralocorticoid activity). Causes less weight gain and water retention, greater reduction in acne, hirsutism and PCOS. Can reduce blood pressure. Side effects include K retention.
No evidence of improved cycle control with multiphasic preparations, and they cannot be taken continuously in order to skip bleeds.Start date varies: on day 1 of menstruation, first Sunday after menstruation, day 5 of cycle
Yasmin: contains synthetic progestin chemically related to spironolactone (with anti-androgen and anti-mineralocorticoid activity). Causes less weight gain and water retention, greater reduction in acne, hirsutism and PCOS. Can reduce blood pressure. Side effects include K retention.
No evidence of improved cycle control with multiphasic preparations, and they cannot be taken continuously in order to skip bleeds.
19. Extended-cycle/continuous OCPs Increase the time between hormone-free intervals or decrease the number of hormone-free days in each cycle
Effective at reducing or eliminating scheduled withdrawal bleeding
Associated with more frequent unscheduled bleeding or spotting
20. Extended-cycle/continuous OCPs Advantages when compared to usual combined OCPs include reduction in:
Hormone withdrawal symptoms
PMS and PMDD
Irregular bleeding
Headaches
Side effects and contraindications are similar to combined OCPs. It is unknown whether extra weeks of hormone exposure increase risk of thromboembolism.
21. Extended Cycle/Continuous OCPs 84/7 regimens: Seasonale and Seasonique
24/4 regimens: Yaz and Loestrin 24 Fe
Lybrel: No placebo or pill-free interval. No head to head trials between Seasonal and Seasonique but Seasonique seems to have less bleeding. Same hormones but seasonique has ethinyl estradiol in the 7 pills
Yaz, like Yasmin, contains synthetic progestin drospirenone with anti-androgen and anti-mineralocorticoid activity, and therefore causes less weight gain and water retention, has greater reduction in acne, PMDD, hirsutism, PCOS, and BPNo head to head trials between Seasonal and Seasonique but Seasonique seems to have less bleeding. Same hormones but seasonique has ethinyl estradiol in the 7 pills
Yaz, like Yasmin, contains synthetic progestin drospirenone with anti-androgen and anti-mineralocorticoid activity, and therefore causes less weight gain and water retention, has greater reduction in acne, PMDD, hirsutism, PCOS, and BP
22. Progestin-Only OCPs Suppresses ovulation, has variable dampening effect on midcycle peaks of LH and FSH, increases cervical mucus viscosity, leads to atrophic endometrium, reduces cilia motility in the fallopian tube
**MUST BE TAKEN AT THE SAME TIME EVERY DAY** If a pill is delayed by three hours it is considered missed and extra precautions must be taken for 7-14 daysIf a pill is delayed by three hours it is considered missed and extra precautions must be taken for 7-14 days
23. Progestin-Only OCP Advantages:
Risk of serious complications to which estrogen contributes is greatly reduced
Decreased dysmenorrhea, menstrual blood loss, PMS symptoms
Fertility returns immediately after cessation
Disadvantages:
**requires compliance**
Does not protect against STDs
Therefore can be use in women unable to take estrogen due to breastfeeding, cardiovascular disease including diabetes, breast cancer, migraine, in women with h/o DVTTherefore can be use in women unable to take estrogen due to breastfeeding, cardiovascular disease including diabetes, breast cancer, migraine, in women with h/o DVT
24. Progestin-Only OCP: Side effects Menstrual irregularities
Spotting, breakthrough bleeding
Amenorrhea
Weight gain
Headache
Adverse impact on lipids
Mood changes
Severe depression
Acne
Hypoestrogenism
Hair loss
25. Progestin-Only OCPs Contraindications: pregnancy, current breast cancer, vaginal bleeding
Caution: breastfeeding < 6 weeks postpartum, active viral hepatitis, hypertension >160/100, current ischemic heart disease, h/o stroke, current DVT or pulmonary embolism, diabetes w/ vascular disease, severe decompensated cirrhosis
26. Progestin-Only OCPs: Examples Ovrette (0.075 mg Norgestrel)
Micronor or Nor-QD (0.35 mg norethindrone)
First pill is taken on day 1 of menstruation
27. Emergency Contraception Progestin-only:
Plan B (levonorgestrel 0.75 mg)
Norgestrel 1.5 mg
Combined:
Norgestrel 100 mg, ethinyl estradiol 100 mcg
Levonorgestrel 50 mg, ethinyl estradiol 100 mcg
First dose < 72 hours after unprotected intercourse, second dose 12 hours later
28. Injectable Contraceptives Depo-Provera
29. Injectable Contraceptives (Depo-Provera) Progestin-only: Depo-medroxyprogesterone acetate (DMPA) 150 mg IM every 12 weeks
Alters endometrial lining, thickens cervical mucus and blocks LH surge preventing ovulation
30. Depo-Provera Advantages
Extremely effective. Failure rate 0.3% with perfect use, 3% with typical use.
Efficacy is not altered by varying weight nor use of concurrent medications nor sickness/diarrhea
Decreased anemia, dysmenorrhea
Decreased risk of endometrial and ovarian ca, PID, ectopics
Safe for use in breast-feeding mothers
Does not produce serious side effects of estrogen: OK to use in patients with diabetes, lipid disorders, complicated migraines, h/o CVA/CAD/CHF, SLE, peripheral vascular disease
Disadvantages
Involves injections and remembering to visit MD every 3 months
Persistent irregular bleeding
Delayed return to fertility
Weight gain-about 5 lbs in first year.
Depression
Consider in patients on anti-convulsants!Consider in patients on anti-convulsants!
31. Side effects of Depo-Provera Edema, thromboembolic disorders
Nausea, vomiting, diarrhea, abdominal pain
Hot flashes, decreased libido, menstrual changes, breast tenderness, galactorrhea
Weight gain
Headache, insomnia, dizziness, depression, fatigue, nervousness
Rashes, alopecia, acne, urticaria, pruritus
Injection site reactions
Can cause decreased bone mineral density, but this is not associated with increased fracture risk, is transient and reversible upon discontinuation.
32. Contraindications to Depo-Provera Known or suspected pregnancy
Undiagnosed vaginal bleeding or missed abortion
Known or suspected malignancy of the breast
Active thrombophlebitis, current thromboembolic disease, or cerebral vascular disease
Liver dysfunction or disease
33. Contraceptive Patch Ortho Evra
34. Ortho Evra Apply once weekly for 3 weeks. Placebo is one patch-free week during which withdrawal bleeding occurs
Blocks LH surge (preventing ovulation), thickens cervical mucus, alters endometrial lining Apply to abdomen, buttock, upper arm or outer torsoApply to abdomen, buttock, upper arm or outer torso
35. Ortho Evra Efficacy similar to OCPs: 0.3% failure rate with perfect use, 8% with typical use.
Once a week regimen may be easier for some patients to follow compared to daily pill
Less effective in women who weigh > 90 kg
Side effects, contraindications, cardiovascular risk similar to combined OCPs
May also have application site reactions, 1-2 patches per year per user may fall off, and there is likely increased risk of VTE compared to combined OCPs
36. Vaginal Ring NuvaRing
37. NuvaRing Ethylvinyl acetate ring
Ethinyl estradiol 0.015 mg/day +etonogestrel 0.12 mg/day
Inserted intravaginally for three weeks
Thickens cervical mucus, alters endometrial lining, blocks LH surge preventing ovulation
38. NuvaRing Side effects, contraindications similar to combined OCPs. Ring specific:
2.5% of women will have 1 event/year where ring falls out
Leukorrhea/vaginitis Leukorrhea-thick white vaginal dischargeLeukorrhea-thick white vaginal discharge
39. Intrauterine Devices
Copper T 380A
Mirena
40. IUDs Copper T IUD
Causes migration of WBCs into the uterine cavity resulting in phagocytosis of spermatozoa
Copper ions seem to have direct toxic effect on spermatozoa
Can be left in place for 10 yrs
Bleeding: Increases flow 50%, regular periods, 7-12% remove for bleeding and/or pain at 1 year Mirena
Releases 20 mcg LNG per day into uterine cavity for 5 years
Inhibits fertilization: anovulation, thickens cervical mucus, inhibits sperm and ovum motility and function
Can be left in place for 5 years
Bleeding: Decreases flow 90%, irregular periods w/ spotting, 20% amenorrheic at 1 year, 7% remove for bleeding within 1 year
41. IUDs Advantages:
Efficacy. Failure rate w/ perfect use 0.1-0.6%, typical use 0.1-0.8%
Long-term
Reversible
Most cost-effective
No systemic side effects
Mirena only: decreased menorrhagia, dysmenorrhea, anemia
Decreased rate of ectopic pregnancies overall*
Disadvantages
Increased risk of PID (only at insertion)
Risk of perforation with insertion
Cramping and pain at insertion
May be expelled unnoticed
No STD protection
REQUIRES COUNSELING, HISTORY, PELVIC EXAM, SCREEN FOR GONORRHEA/CHLAMYDIA and PAP SMEAR** *but ratio of extrauterine to intrauterine pregnancy is increased if conception does occur.
**This is not felt to be the case for hormonal contraception?only necessary screening prior to prescribing is complete medical history and BP check. Women who are older and therefore at greater risk for breast ca and cervical ca should be advised strongly about importance of pap smears and clinical breast exam for detecting these conditions. *but ratio of extrauterine to intrauterine pregnancy is increased if conception does occur.
**This is not felt to be the case for hormonal contraception?only necessary screening prior to prescribing is complete medical history and BP check. Women who are older and therefore at greater risk for breast ca and cervical ca should be advised strongly about importance of pap smears and clinical breast exam for detecting these conditions.
42. Contraindications to IUDs High risk for STDs
Current cervicitis or PID
Known or suspected pregnancy
Uterine anatomy interfering w/ placement
AIDS, not doing well on ARV therapy
Mirena only: Current DVT
Copper only: Allergy to copper or Wilsons dz
Gynecologic or breast malignancy
Unexplained vaginal bleeding
43. References Himmerick, Kirstine A. Enhancing contraception: A comprehensive review. JAAPA 2005;18:26-33.
Nelson, Anita. Communicating with Patients about Extended-Cycle and Continuous Use of Oral Contraceptives. Journal of Womens Health 2007;16:463-470.
Scott, Alison and Anna Glasier. Evidence based contraceptive choices. Best Practice and Research Clinic Obstetrics and Gynaecology 2006;20:665-680.
44. References Contraception. First Consult. Online. 30 July 2008.
Spencer, Abby, Rachel Bonnema, Megan Cunnane, Alda-Maria Gonzaga, and Mindy Sobota. Contraception: What Every Internist Should Know. SGIM Annual Meeting. Sheraton Center Toronto Hotel, Toronto. 27 April 2007.
Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs. evidence. JAMA 2001;285:2232-9.
45. Acknowledgements Amy Weil, MD